Robert Charles Breedlove - 03 Nov 2025 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Signature
/s/ Robert Charles Breedlove
Issuer symbol
PHAT
Transactions as of
03 Nov 2025
Net transactions value
-$7,079
Form type
4
Filing time
05 Nov 2025, 16:30:03 UTC
Previous filing
09 Sep 2025
Next filing
19 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Breedlove Robert Charles Principal Accounting Officer C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK /s/ Robert Charles Breedlove 05 Nov 2025 0002066645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale $7,079 -524 -1.1% $13.51 47,407 03 Nov 2025 Direct F1
holding PHAT Common Stock 6,945 03 Nov 2025 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.